Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
1.790
+0.060 (3.47%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Skye Bioscience Employees
Skye Bioscience had 16 employees as of December 31, 2024. The number of employees increased by 5 or 45.45% compared to the previous year.
Employees
16
Change (1Y)
5
Growth (1Y)
45.45%
Revenue / Employee
n/a
Profits / Employee
-$1,660,445
Market Cap
55.44M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
SKYE News
- 8 days ago - A Weight Loss Drug Candidate Essentially For Free As Skye Bioscience Is Trading At Cash Value - Seeking Alpha
- 9 days ago - Skye Bioscience's Obesity Candidate Shows 30% Weight Loss When Combined With Eli Lilly's Blockbuster Drug In Animal Models - Benzinga
- 9 days ago - Skye Bioscience Demonstrates Over 30% Weight Loss with Nimacimab and Tirzepatide Combination in Preclinical Model - GlobeNewsWire
- 10 days ago - Skye Bioscience to Conduct Meetings at Piper Sandler Conference - GlobeNewsWire
- 5 weeks ago - Skye Bioscience, Inc. (SKYE) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025 - GlobeNewsWire
- 2 months ago - Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Skye Bioscience to Present at TD Cowen Health Care Conference - GlobeNewsWire